Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Change in Account Payables: 2014-2024

Historic Change in Account Payables for Protagonist Therapeutics (PTGX) over the last 11 years, with Dec 2024 value amounting to $842,000.

  • Protagonist Therapeutics' Change in Account Payables rose 781.13% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 55.22%. This contributed to the annual value of $842,000 for FY2024, which is 129.36% up from last year.
  • According to the latest figures from FY2024, Protagonist Therapeutics' Change in Account Payables is $842,000, which was up 129.36% from -$2.9 million recorded in FY2023.
  • Protagonist Therapeutics' 5-year Change in Account Payables high stood at $2.0 million for FY2022, and its period low was -$2.9 million during FY2023.
  • For the 3-year period, Protagonist Therapeutics' Change in Account Payables averaged around $6,333, with its median value being $842,000 (2024).
  • Per our database at Business Quant, Protagonist Therapeutics' Change in Account Payables soared by 211.57% in 2022 and then slumped by 240.24% in 2023.
  • Protagonist Therapeutics' Change in Account Payables (Yearly) stood at $1.5 million in 2020, then crashed by 224.61% to -$1.8 million in 2021, then surged by 211.57% to $2.0 million in 2022, then slumped by 240.24% to -$2.9 million in 2023, then surged by 129.36% to $842,000 in 2024.